Slingshot members are tracking this event:
FDA Grants Priority Review for Opdivo (nivolumab) in Previously Treated dMMR or MSI-H Metastatic Colorectal Cancer - PDUFA set for Aug. 2, 2017
Slingshot Insights Explained
Aug 01, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Opdivo, Nivolumab, Pdufa, Dmmr, Msi-h Metastatic Colorectal Cance, Colorectal Cancer